AP
ARGX icon

Antipodes Partners’s argenx ARGX Stock Holding History

Antipodes Partners’s Portfolio ARGX Stock Details ARGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
187
+137
+274% +$113K ﹤0.01% 96
2026
Q1 		$36.5K Sell
50
-146
-74% -$114K ﹤0.01% 110
2025
Q4 		$165K Sell
196
-91
-32% -$77.9K ﹤0.01% 88
2025
Q3 		$212K Sell
287
-45
-14% -$29.7K ﹤0.01% 78
2025
Q2 		$183K Buy
332
+5
+2% +$2.9K 0.01% 64
2025
Q1 		$194K Buy
327
+211
+182% +$133K 0.01% 59
2024
Q4 		$71.3K Buy
116
+62
+115% +$36.3K ﹤0.01% 66
2024
Q3 		$29.3K Sell
54
-25
-32% -$12.6K ﹤0.01% 77
2024
Q2 		$34K Hold
79
– – ﹤0.01% 68
2024
Q1 		$31K Hold
79
– – ﹤0.01% 67
2023
Q4 		$30K Hold
79
– – ﹤0.01% 67
2023
Q3 		$38K Buy
79
+20
+34% +$9.78K ﹤0.01% 62
2023
Q2 		$22K Hold
59
– – ﹤0.01% 64
2023
Q1 		$21K Sell
59
-39
-40% -$14.4K ﹤0.01% 65
2022
Q4 		$37K Buy
+98
New +$36.7K ﹤0.01% 59

Other funds holding ARGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Antipodes Partners's ARGX Position: Q2 2026 in Review

Antipodes Partners increased its argenx (ARGX) stake by 274% in Q2 2026, buying an estimated $113K and bringing the position to 187 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #96.

Antipodes Partners first reported a position in ARGX in Q4 2022 and has held it in 15 quarters since. The position peaked at $212K in Q3 2025. 506 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • Antipodes Partners held 187 shares of argenx worth $173K as of Q2 2026.
  • Antipodes Partners bought 137 argenx shares in Q2 2026, an estimated $113K.
  • argenx made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #96 holding.
  • Antipodes Partners first reported a position in argenx in Q4 2022 and has held it in 15 quarters since.
  • Antipodes Partners's argenx position peaked at $212K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.